Bat gene provides insight into fighting COVID-19 and other viral diseases

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.

Emergent wins $75m BARDA contact for anthrax vaccine

Share this article The current $75m contract option builds on an existing Cyfendus development contract between Emergent and BARDA. Image Credit: Niyazz / Shutterstock. Emergent

November 28, 2023

Omitting Axillary Lymph Node Dissection in Early Breast Cancer

Recently, omission of axillary lymph node dissection among patients with early breast cancer has been found to have no detrimental effect on outcomes in most

December 24, 2024

Innovent receives approval from China’s NMPA for SINTBILO

SINTBILO is approved in China to treat adult patients with primary hypercholesterolemia and mixed dyslipidemia. Credit: Naeblys / Shutterstock.com. Innovent Biologics has secured approval from

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.